We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Endoscopic System Reduces Procedure Costs by Half

By HospiMedica International staff writers
Posted on 08 Aug 2013
A new, cost-effective endoscopic option for urological procedures helps visualize body cavities or organs.

The Flexor Vue Deflecting Endoscopic System is typically used for flexible ureteroscopy, but can also be used in other kidney and bladder procedures. More...
The system includes a one-time-use disposable sheath, a 3-mm bundle of fiber optics, and a visualization source that can be reused up to ten times with careful handling. The cost of the system is 50% less than a normal endoscopic system and it is available off the shelf, thus aimed at physicians who do not require a cystoscopy or ureteroscopy for managing stone, kidney, and bladder procedures.

Among the benefits of the system are significant reductions in risk of patient-to-patient biological cross-contamination, due to the device’s disposable nature; elimination of the need for costly repairs and/or replacement of a scope if damaged; and an improved cost accounting on a per-case basis. The Flexor Vue Deflecting Endoscopic System is a product of Cook Medical (Bloomington, IN, USA; www.cookmedical.com), and has been approved by the US Food and Drug Administration (FDA).

“We believe the Flexor Vue will support physicians in many cases,” said Jean-Marc Creissel, global leader of Cook’s Urology division. “The system ensures that they will not have to reschedule procedures because their scope breaks or isn’t sterile. The Flexor Vue is convenient, disposable and could improve patient safety by preventing patient-to-patient contamination.”

Related Links:

Cook Medical



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.